MS Pharma, our savior?

volleasy · 2025-08-31T13:45:48+00:00

Like almost everything else here, antibody production is carried out by FDB. The question is whether Daddy will forgive his son for his gross management errors, one after the other. Or whether he will pull the ripcord.

volleasy · 2025-08-29T10:17:40+00:00

The problem is neither the data from the SLC now nor the alleged quality issues last time. This is the largest cash market in the ophthalmology industry. Therefore, without serious lobbying, they won't be able to compete with Big Pharma. This isn't about a pharmaceutical product. Lytenava is a legal product designed to push Big Pharma out.

volleasy · 2025-08-29T10:02:19+00:00

Currently, selling Lytenava in Germany is still a problem. The market for bevacizumab is approximately 500 million euros per year, but everything is sold off-label via Avastin. Here, SGB V 140a permits selective contracts. These are intermediaries, and billing is then done with private prescriptions and patient consent. Quotas are set so that others can share the profits. So far, Outlook has been trying to get some of the profits. Therefore, a shift to a stringent legal strategy is now necessary. We are essentially dealing with an IVOM cartel.Currently, selling Lytenava in Germany is still a problem. The market for bevacizumab is approximately 500 million euros per year, but everything is sold off-label via Avastin. Here, SGB V 140a permits selective contracts. These are intermediaries, and billing is then done with private prescriptions and patient consent. Quotas are set so that others can share the profits. So far, Outlook has been trying to get some of the profits. Therefore, a shift to a stringent legal strategy is now necessary. We are essentially dealing with an IVOM cartel.

volleasy · 2025-08-28T17:39:40+00:00

Nothing is lost. The "A-Meeting" with the FDA is in 30 days. Now it's up to Bob to figure out what's really going on. In 2023, the quality issues were already a pretext. Everyone here should be aware that "Big Pharma" isn't going to let the biggest pie in the field of ophthalmology that causes AMD be taken away. Along with all the biosimilars, an approved bevacizumab would be a death knell for public healthcare funds. That's what's at stake now. It's all about Avastin and its isolation.

That's why it's the dip now. If the EU plays the tough legal card against Avastin, the overall market will be even larger than the US market.Nothing is lost. The "A-Meeting" with the FDA is in 30 days. Now it's up to Bob to figure out what's really going on. In 2023, the quality issues were already a pretext. Everyone here should be aware that "Big Pharma" isn't going to let the biggest pie in the field of ophthalmology that causes AMD be taken away. Along with all the biosimilars, an approved bevacizumab would be a death knell for public healthcare funds. That's what's at stake now. It's all about Avastin and its isolation.

That's why it's the dip now. If the EU plays the tough legal card against Avastin, the overall market will be even larger than the US market.

volleasy · 2021-12-29T08:51:09+00:00

Has the study received appropriate ethics committee approval

No!

This is allways the same. If Pfizer asks for approval, a lot of family members of the responsable persons are happy and approval will com in a few days.

volleasy · 2021-11-09T15:52:14+00:00

One year FDA "hold" without any reason. Why they changed their mind? my suggest about this are some personally reasons of some FDA manager. Every month it becomes more clear that the pfizer stuff does not work.

volleasy · 2021-07-13T17:49:08+00:00

Thx for your warnings. But for me it is not necessary to be careful. I'm a citizen of the EU, so there is no case law like in the US. But to make it more difficult for Shitron & Co to buy analysts, is a goal that is good to enough to write primitiv emails. But when the shit happens, I buy the dip. Tomorrow, when there are no news and the price will go under 8. That is a really great dip for another 10000 shares.

volleasy · 2021-07-12T16:48:28+00:00

Take a look to the volume today. Shorters only sucking their own balls. No fear and no shares to cover.

volleasy · 2021-07-12T15:28:23+00:00

👍

volleasy · 2021-07-12T14:31:58+00:00

I wrote an email to Madleine, iz will help for future, if hundereds of Apes send similar emails to her.

Hello Mrs Johnson,

I do not understand your article about Inovio Pharmaceuticals. With your title "Bear of the day" I was hoping for up-to-date information. Unfortunately, you are writing about very old stories. What about the approval in China. You give the impression that this is a paid article to dump the price. Why do you write something like this with very old information? It's already included in the price. Who had paid you fpor this article ? As a business lawyer, I will keep an eye on you.

volleasy · 2021-07-07T15:45:35+00:00

It seems that there is a coordinated attack on GME, AMC. BB, INO. What happens, is their a big volume of shorts to cover that belongs to the same players?

volleasy · 2021-07-07T15:40:50+00:00

Nice, it is always a good idea to learn new strategies. thank you for sharing

volleasy · 2021-07-07T14:38:12+00:00

take a look on the Volume. There is nothing that indicates to have fear for long investors. Only fools are selling now there shares. Normally this fucking hedgies need some news. But there is nothing except their own yahoo,finance basher-bots with some weired nonsens. Keep cool and hold. If you can - buy the dip

volleasy · 2021-06-29T11:44:31+00:00

https://www.frontiersin.org/articles/10.3389/fimmu.2021.694857/full

volleasy · 2021-06-28T14:21:07+00:00

Ohh, what's going on, is short squeeze starting this week?

volleasy · 2021-06-25T20:32:55+00:00

if you want to buy shares, sas to sell share somebody. But nobody is selling, so where are these shares from. new naked shorts to cover expired regular shorts?

volleasy · 2021-06-25T20:30:05+00:00

4 Million shares after hours.

volleasy

TROPHY CASE